Efficacy of rituximab in autoimmune hemolytic anemia associated with splenic marginal zone lymphoma.
Fozza
Claudio
C
Galleu
Antonio
A
Careddu
Maria Grazia
MG
Giannico
Domenica Barbara
DB
Bonfigli
Silvana
S
Contini
Salvatore
S
Longinotti
Maurizio
M
D000368:Aged; D000744:Anemia, Hemolytic, Autoimmune / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D058846:Antibodies, Monoclonal, Murine-Derived / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D000069283:Rituximab; D013160:Splenic Neoplasms / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D058846:Antibodies, Monoclonal, Murine-Derived; D000069283:Rituximab